Document Type : Original Research


1 Gastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran

2 Department of Pathology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran

3 Gut and Liver Research Center, Department of Gastroenterology, Imam Hospital, Mazandaran University of Medical Sciences, Sari, Iran

4 Gut and Liver Research Center, Department of Gastroenterology, Imam Hospital, Mazandaran University of Medical Sciences, Sari, Iran.


Background & Objective: Leptin is an adipocyte-derived hormone with a critical role in energy balance. As demonstrated by previous investigations, leptin acts as a proliferative and angiogenic factor in cancer cells. However, results regarding its role in colorectal cancer are still inconclusive. We aimed to evaluate serum leptin and tissue expression of leptin receptor (Ob-R) in normal and malignant samples of colorectal.
Methods: Serum and tissue samples from pathology-confirmed colorectal cancer patients and normal controls referring to a university hospital of Mazandaran were obtained during 2019-21. ELISA and immunohistochemistry were applied to determine leptin and Ob-R expression respectively.
Results: A total of 90 samples belonging to 46 normal and 44 CRC patients were enrolled. Normal and CRC groups included 32 (69.56%) and 21 (47.72%) female subjects respectively. The average leptin concentration in the normal group was 115.80 and, in the patient, group was 124.47 ng/mL (P=0.897). CRC cases showed an insignificantly higher Ob-R detection rate (P=0.086).
Conclusion: There was no significant difference in leptin and Ob-R expression between CRC patients and normal subjects. Thus, leptin and its receptor may not be useful as a biomarker of CRC.


Main Subjects

  1. Dornbush S, Aeddula NR. Physiology, Leptin. [Updated 2022 Apr 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: [
  2. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes. 1996;45(11):1455-62. [DOI:10.2337/diab.45.11.1455] [PMID]
  3. Zhang Y, Chua Jr S. Leptin function and regulation. Comprehensive physiology. 2011;8(1):351-69. [DOI:10.1002/cphy.c160041]
  4. Tokuyama-Toda R, Satomura K. The Physiological Roles of Leptin in Skin Wound Healing. Wound Healing-New insights into Ancient Challenges: IntechOpen; 2016. [DOI:10.5772/63368]
  5. Geary N. Hunger and Satiation. In: Martini L, editor. Encyclopedia of Endocrine Diseases. New York: Elsevier; 2004. p. 459-68. [DOI:10.1016/B0-12-475570-4/01166-5]
  6. Mengie Ayele T, Tilahun Muche Z, Behaile Teklemariam A, Bogale Kassie A, Chekol Abebe E. Role of JAK2/STAT3 Signaling Pathway in the Tumorigenesis, Chemotherapy Resistance, and Treatment of Solid Tumors: A Systemic Review. J Inflamm Res. 2022;15:1349-64. [DOI:10.2147/JIR.S353489] [PMID] [PMCID]
  7. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49. [DOI:10.3322/caac.21660] [PMID]
  8. Maajani K, Khodadost M, Fattahi A, Shahrestanaki E, Pirouzi A, Khalili F, et al. Survival Rate of Colorectal Cancer in Iran: A Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev. 2019;20(1):13-21. [DOI:10.31557/APJCP.2019.20.1.13] [PMID] [PMCID]
  9. Wong MC, Ding H, Wang J, Chan PS, Huang J. Prevalence and risk factors of colorectal cancer in Asia. Intest Res. 2019;17(3):317-29. [DOI:10.5217/ir.2019.00021] [PMID] [PMCID]
  10. Bahr I, Jaeschke L, Nimptsch K, Janke J, Herrmann P, Kobelt D, et al. Obesity, colorectal cancer and MACC1 expression: A possible novel molecular association. Int J Oncol. 2022;60(2):1-11. [DOI:10.3892/ijo.2022.5307] [PMID] [PMCID]
  11. Uddin S, Hussain AR, Khan OS, Al-Kuraya KS. Role of dysregulated expression of leptin and leptin receptors in colorectal carcinogenesis. Tumour Biol. 2014;35(2):871-9. [DOI:10.1007/s13277-013-1166-4] [PMID]
  12. Haque I, Ghosh A, Acup S, Banerjee S, Dhar K, Ray A, et al. Leptin-induced ER-alpha-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway. BMC Cancer. 2018;18(1):99. [DOI:10.1186/s12885-018-3993-6] [PMID] [PMCID]
  13. Aparicio T, Kotelevets L, Tsocas A, Laigneau JP, Sobhani I, Chastre E, et al. Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in Apc(Min/+) mice. Gut. 2005;54(8):1136-45. [DOI:10.1136/gut.2004.060533] [PMID] [PMCID]
  14. Park KB, Kim EY, Chin H, Yoon DJ, Jun KH. Leptin stimulates migration and invasion and maintains cancer stem‑like properties in gastric cancer cells. Oncol Rep. 2022;48(3):1-10. [DOI:10.3892/or.2022.8377] [PMID] [PMCID]
  15. Fenton JI, Lavigne JA, Perkins SN, Liu H, Chandramouli GV, Shih JH, et al. Microarray analysis reveals that leptin induces autocrine/paracrine cascades to promote survival and proliferation of colon epithelial cells in an Apc genotype-dependent fashion. Mol Carcinog. 2008;47(1):9-21. [DOI:10.1002/mc.20357] [PMID]
  16. Kumor A, Daniel P, Pietruczuk M, Malecka-Panas E. Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis. 2009;24(3):275-81. [DOI:10.1007/s00384-008-0605-y] [PMID]
  17. Meerson A, Yehuda H. Leptin and insulin up-regulate miR-4443 to suppress NCOA1 and TRAF4, and decrease the invasiveness of human colon cancer cells. BMC Cancer. 2016;16(1):882. [DOI:10.1186/s12885-016-2938-1] [PMID] [PMCID]
  18. Endo H, Hosono K, Uchiyama T, Sakai E, Sugiyama M, Takahashi H, et al. Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis. Gut. 2011;60(10):1363-71. [DOI:10.1136/gut.2010.235754] [PMID]
  19. Socol CT, Chira A, Martinez-Sanchez MA, Nunez-Sanchez MA, Maerescu CM, Mierlita D, et al. Leptin Signaling in Obesity and Colorectal Cancer. Int J Mol Sci. 2022;23(9):4713. [DOI:10.3390/ijms23094713] [PMID] [PMCID]
  20. Montazer F, Alizadeh-Navaei R. Expression of GLUT1 in Neoplastic Cells of Papillary Thyroid Cancer. Turkish Journal of Oncology. 2019;34(4). [DOI:10.5505/tjo.2019.1994]
  21. Uchiyama T, Takahashi H, Sugiyama M, Sakai E, Endo H, Hosono K, et al. Leptin receptor is involved in STAT3 activation in human colorectal adenoma. Cancer Sci. 2011;102(2):367-72. [DOI:10.1111/j.1349-7006.2010.01803.x] [PMID]
  22. Fantuzzi G. Three questions about leptin and immunity. Brain Behav Immun. 2009;23(4):405-10. [DOI:10.1016/j.bbi.2008.10.007] [PMID] [PMCID]
  23. Aparicio T, Kotelevets L, Tsocas A, Laigneau J-P, Sobhani I, Chastre E, et al. Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in ApcMin/+ mice. Gut. 2005;54(8):1136-45. [DOI:10.1136/gut.2004.060533] [PMID] [PMCID]
  24. Uddin S, Bavi PP, Hussain AR, Alsbeih G, Al-Sanea N, Abduljabbar A, et al. Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication. Carcinogenesis. 2009;30(11):1832-40. [DOI:10.1093/carcin/bgp145] [PMID]
  25. Tutino V, Notarnicola M, Guerra V, Lorusso D, Caruso MG. Increased soluble leptin receptor levels are associated with advanced tumor stage in colorectal cancer patients. Anticancer Res. 2011;31(10):3381-3.
  26. M SV, V SM, S AJ, J TZ, M SK, F CV. Clinical significance of Leptin receptor (LEPR) and Endoglin (CD105) expressions in colorectal adenocarcinoma. Journal of BUON : official journal of the Balkan :union: of Oncology. 2019;24(6):2448-57.
  27. Aleksandrova K, Boeing H, Jenab M, Bueno-de-Mesquita HB, Jansen E, van Duijnhoven FJ, et al. Leptin and soluble leptin receptor in risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition cohort. Cancer Res. 2012;72(20):5328-37. [DOI:10.1158/0008-5472.CAN-12-0465] [PMID]
  28. Bolukbas FF, Kilic H, Bolukbas C, Gumus M, Horoz M, Turhal NS, et al. Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study. BMC Cancer. 2004;4:29. [DOI:10.1186/1471-2407-4-29] [PMID] [PMCID]
  29. Lee JY, Lee HS, Lee DC, Chu SH, Jeon JY, Kim NK, et al. Visceral fat accumulation is associated with colorectal cancer in postmenopausal women. PLoS One. 2014;9(11):e110587. [DOI:10.1371/journal.pone.0110587] [PMID] [PMCID]
  30. Park JW, Chang SY, Lim JS, Park SJ, Park JJ, Cheon JH, et al. Impact of Visceral Fat on Survival and Metastasis of Stage III Colorectal Cancer. Gut Liver. 2022;16(1):53-61. [DOI:10.5009/gnl20266] [PMID] [PMCID]
  31. Song SO, Han SJ, Kahn SE, Leonetti DL, Fujimoto WY, Boyko EJ. Leptin and Adiponectin Concentrations Independently Predict Future Accumulation of Visceral Fat in Nondiabetic Japanese Americans. Obesity (Silver Spring). 2021;29(1):233-9. [DOI:10.1002/oby.23035] [PMID]
  32. Nam SY, Choi IJ, Ryu KH, Park BJ, Kim YW, Kim HB, et al. The effect of abdominal visceral fat, circulating inflammatory cytokines, and leptin levels on reflux esophagitis. J Neurogastroenterol Motil. 2015;21(2):247-54. [DOI:10.5056/jnm14114] [PMID] [PMCID]
  33. Genske F, Kuhn JP, Pietzner M, Homuth G, Rathmann W, Grabe HJ, et al. Abdominal fat deposits determined by magnetic resonance imaging in relation to leptin and vaspin levels as well as insulin resistance in the general adult population. Int J Obes (Lond). 2018;42(2):183-9. [DOI:10.1038/ijo.2017.187] [PMID]
  34. Jiménez-Cortegana C, López-Saavedra A, Sánchez-Jiménez F, Pérez-Pérez A, Castiñeiras J, Virizuela-Echaburu JA, et al. Leptin, Both Bad and Good Actor in Cancer. Biomolecules. 2021;11(6):913. [DOI:10.3390/biom11060913] [PMID] [PMCID]